Reuters: Haleon makes oral-health push in China as other Western brands falter

Overview

In March 2026, Reuters reported on Haleon’s latest expansion efforts in China, highlighting the company’s investment plans, focus areas and product strategy. Key points from the coverage include:

• Expansion in China — Haleon is investing £65 million in a new oral health manufacturing site in Shanghai and increasing its presence in second  and third tier cities to meet rising demand for everyday health products.
• Focus on gum health demand — With more than 70% of Chinese consumers estimated to experience gum health issues, Haleon is scaling its parodontax gum health brand in response, targeting more than 30 Chinese cities by 2027.
• Role of local adaptation – parodontax was relaunched in China in 2024 with features adapted to local preferences - including a sweeter and more fragrant flavour, foamier texture and more premium packaging - to increase its appeal to Chinese consumers.

The coverage also quotes CEO Brian McNamara who said: “For us, China’s an incredible market…Over 70% of consumers in China suffer from gum health issues. We have a product to address it. There’s a clear consumer need.” 

And Jayant Singh, Global Head of Oral Health, who emphasised the importance of adapting to local flavour profiles, saying: “It’s these minor nuances that you need to put into your mix to really drive acceptance.”